HIGH

Boothwyn Pharmacy Recalls Semaglutide Injection for Low Potency

Boothwyn Pharmacy recalled 186 vials of Semaglutide, 2.5 mg/mL injection on July 9, 2025. The product is subpotent and poses a risk to consumers. Healthcare providers and consumers should stop using this product immediately.

Quick Facts at a Glance

Recall Date
July 9, 2025
Hazard Level
HIGH
Brand
Boothwyn Pharmacy
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Subpotent Drug

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for guidance. Notification method: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Product Details

Semaglutide, 2.5 mg/mL injection, 0.8 mL, is sold under the brand Boothwyn Pharmacy. The recall affects 186 vials distributed nationwide in the U.S. The recall was classified as Class II.

The Hazard

The recalled Semaglutide injection may not provide the intended therapeutic effect due to being subpotent. This could lead to inadequate treatment for conditions it is prescribed for, potentially impacting patient health.

Reported Incidents

No specific incidents or injuries have been reported related to this recall. The risk remains high due to the possibility of ineffective treatment.

What to Do

Consumers should stop using the recalled Semaglutide injection immediately. Contact Boothwyn Pharmacy LLC or your healthcare provider for further guidance.

Contact Information

For more information, contact Boothwyn Pharmacy LLC via email or phone. Additional details are available at the FDA's recall page.

Key Facts

  • 186 vials recalled nationwide
  • Subpotent drug poses health risks
  • Class II recall status
  • Consumers urged to stop use immediately

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
03202025@9 BUD 07/18/2025
Affected States
ALL
Report Date
September 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

HIGH

Acuity Specialty Products Recalls Hand Sanitizer Due to Methanol Risk

Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.

Acuity Specialty Products
cGMP deviations:
Read more
HIGH

AFCO Hand Sanitizer Recalled Due to Methanol Risk

AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.

AFCO
cGMP deviations:
Read more